Show simple item record

Stabilnost lekova - industrijski aspect

dc.creatorSolomun, Ljiljana
dc.creatorIbrić, Svetlana
dc.creatorPejanović, Vjera
dc.date.accessioned2019-09-02T11:26:19Z
dc.date.available2019-09-02T11:26:19Z
dc.date.issued2011
dc.identifier.issn0004-1963
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/1588
dc.description.abstractStability testing is carried out in several phases of new product development. The effect of various external factors on possible formulations, compatibility of active pharmaceutical ingredient, excipients and primary packaging material, is examined in early phases of development. Possible pathways of degradation are defined, and degradation rate is estimated by subjecting the products to different, extreme conditions. The results obtained during this phase of testing are used for defining the testing parameters in formal stability studies. Numerous guidelines, which define the testing parameters, are used in this phase of testing. The principal elements which are defined include testing conditions and testing frequency. An accelerated stability testing is carried out over a period of 6 months, whereby a product is exposed to the temperature exceeding the expected warehousing temperature, while a long-term stability testing is performed under the predicting storage conditions, and the length of testing corresponds to the envisaged shelf life. Photostability testing is carried out within a stress testing, and in certain cases, in use stability testing is carried out, whereby storage conditions and the period within which a product must be used after the first opening, i.e. reconstitution, are defined. Testing results are also used for establishing the final specifications of the quality of medicinal products, particularly from the aspect of degradation products (impurities). Various statistical methods and mathematical models, such as artificial neural networks, are used in results processing for the purpose of estimating the stability in a shorter period of time.en
dc.description.abstractIspitivanje stabilnosti realizuje se u više faza razvoja novog proizvoda. U ranim fazama razvoja ispituju se uticaji različitih spoljašnjih faktora (temperatura, vlaga, svetlost, kiseonik, mikroorganizmi) na potencijalne formulacije, kompatibilnost lekovite supstance, pomoćnih supstanci i kontaktne ambalaže. Kondicioniranjem proizvoda u različitim, ekstremnim uslovima, definišu se mogući putevi degradacije i predviđa brzina degradacije. Rezultati koji se dobiju u toku ove faze ispitivanja koriste se za definisanje parametara ispitivanja u formalnim studijama stabilnosti. U ovoj fazi ispitivanja, primenjuju se brojne smernice kojima se definišu parametri koji će se ispitivati. Osnovni elementi koji se definišu jesu uslovi ispitivanja i frekvenca ispitivanja. Ubrzano ispitivanje stabilnosti sprovodi se u trajanju od 6 meseci, pri čemu se proizvod izlaže temperaturi višoj od očekivane temperature skladištenja; dugotrajno ispitivanje se izvodi pod očekivanim uslovima čuvanja, a dužina ispitivanja se poklapa sa predviđenim rokom trajanja. U okviru stres ispitivanja se vrši i ispitivanje fotostabilnosti, a u pojedinim slučajevima, vrši se ispitivanje in use stabilnosti, pri čemu se definišu uslovi čuvanja i rok u kome se proizvod mora upotrebiti nakon prvog otvaranja, odnosno rekonstitucije. Rezultati ispitivanja koriste se i za postavljanje konačnih specifikacija kvaliteta lekova, posebno sa aspekta degradacionih proizvoda (nečistoća). U obradi rezultata koriste se različite statističke metode i matematički modeli, kao što su veštačke neuronske mreže, u cilju predviđanja stabilnosti u kraćem vremenskom roku.sr
dc.publisherSavez farmaceutskih udruženja Srbije, Beograd
dc.rightsopenAccess
dc.sourceArhiv za farmaciju
dc.subjectstabilityen
dc.subjectstress testingen
dc.subjectformal testingen
dc.subjectphotostabilityen
dc.subjectin use stabilityen
dc.subjectdegradation productsen
dc.subjectartificial neural networksen
dc.subjectstabilnostsr
dc.subjectstres ispitivanjesr
dc.subjectformalno ispitivanjesr
dc.subjectfotostabilnostsr
dc.subjectin use stabilnostsr
dc.subjectdegradacioni proizvodisr
dc.subjectveštačke neuronske mrežesr
dc.titleDrug stability: Industry viewen
dc.titleStabilnost lekova - industrijski aspectsr
dc.typearticle
dc.rights.licenseBY-SA
dcterms.abstractСоломун, Љиљана; Пејановић, Вјера; Ибрић, Светлана; Стабилност лекова - индустријски аспецт; Стабилност лекова - индустријски аспецт;
dc.citation.volume61
dc.citation.issue5
dc.citation.spage449
dc.citation.epage463
dc.citation.other61(5): 449-463
dc.citation.rankM53
dc.identifier.scopus2-s2.0-84858972083
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs//bitstream/id/436/1586.pdf
dc.identifier.rcubconv_453
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record